Prunes May Blunt Adverse Effects of Oral Contraceptives on Bone Health in Young Adult Women: A Randomized Clinical Trial
- PMID: 39310666
- PMCID: PMC11415679
- DOI: 10.1016/j.cdnut.2024.104417
Prunes May Blunt Adverse Effects of Oral Contraceptives on Bone Health in Young Adult Women: A Randomized Clinical Trial
Abstract
Background: Oral contraceptives (OCs) may promote bone loss, thereby leading to suboptimal bone health later in life. Research is needed to determine whether dietary interventions can blunt OC-related bone loss; prune consumption, shown to be effective in improving bone density in previous studies, could provide a safe and inexpensive solution.
Objectives: The purpose of this study was to determine whether 12 mo of consuming 50 g of prunes daily would prevent bone loss or increase bone accrual in young (18-25 y) OC users.
Methods: Ninety women were randomly assigned to a control group not using OCs (non-OC), an OC group not consuming prunes (OC), and an OC group consuming 50 g prunes daily (OC+P) for 12 mo. Bone mineral density (BMD) was measured at baseline and after 12 mo via dual-energy X-ray absorptiometry (at all sites) and peripheral quantitative computed tomography (at tibia). Blood samples were collected at baseline and after 6 and 12 mo to assess biomarkers.
Results: There were no significant differences between groups for dietary intake, physical activity, serum tartrate-resistant acid phosphatase-5b, or bone alkaline phosphatase concentrations. Baseline serum C-reactive protein and vitamin D concentrations were higher (P < 0.001) for OC and OC+P groups than those in the non-OC group. Serum parathyroid hormone was higher for non-OC group than OC group at both baseline (P = 0.049) and final (P = 0.032). BMD measured by dual-energy X-ray absorptiometry at all sites did not change among groups. Ultradistal radius BMD increased over time (P < 0.05) within non-OC and OC+P groups. Trabecular density of the distal tibia as measured by peripheral quantitative computed tomography decreased from baseline to 12 mo within the OC group only (P = 0.016).
Conclusions: OC use tended to promote minor negative effects on bone and consuming prunes tended to provide a potential protective effect on trabecular density of the distal tibia and ultradistal radius.This trial was registered at www.clinicaltrials.gov as NCT04785131.
Keywords: bone health; dried plums; oral contraceptives; osteoporosis; women’s health.
© 2024 The Author(s).
Figures
Similar articles
-
Prunes preserve hip bone mineral density in a 12-month randomized controlled trial in postmenopausal women: the Prune Study.Am J Clin Nutr. 2022 Oct 6;116(4):897-910. doi: 10.1093/ajcn/nqac189. Am J Clin Nutr. 2022. PMID: 35798020 Clinical Trial.
-
Effects of Prune (Dried Plum) Supplementation on Cardiometabolic Health in Postmenopausal Women: An Ancillary Analysis of a 12-Month Randomized Controlled Trial, The Prune Study.J Nutr. 2024 May;154(5):1604-1618. doi: 10.1016/j.tjnut.2024.03.012. Epub 2024 Mar 13. J Nutr. 2024. PMID: 38490532 Free PMC article. Clinical Trial.
-
Prunes preserve cortical density and estimated strength of the tibia in a 12-month randomized controlled trial in postmenopausal women: The Prune Study.Osteoporos Int. 2024 May;35(5):863-875. doi: 10.1007/s00198-024-07031-6. Epub 2024 Feb 13. Osteoporos Int. 2024. PMID: 38349471 Clinical Trial.
-
The Role of Prunes in Modulating Inflammatory Pathways to Improve Bone Health in Postmenopausal Women.Adv Nutr. 2022 Oct 2;13(5):1476-1492. doi: 10.1093/advances/nmab162. Adv Nutr. 2022. PMID: 34978320 Free PMC article. Review.
-
Oral contraceptives for the prevention of osteoporosis.J Reprod Med. 1993 Dec;38(12 Suppl):1015-20. J Reprod Med. 1993. PMID: 8120858 Review.
Cited by
-
Influence of menstrual cycle and oral contraception on taxonomic composition and gas production in the gut microbiome.J Med Microbiol. 2025 Mar;74(3):001987. doi: 10.1099/jmm.0.001987. J Med Microbiol. 2025. PMID: 40153295 Free PMC article.
-
Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women.Pharmaceuticals (Basel). 2025 Jan 8;18(1):61. doi: 10.3390/ph18010061. Pharmaceuticals (Basel). 2025. PMID: 39861124 Free PMC article. Review.
References
-
- Scholes D., Hubbard R.A., Ichikawa L.E., LaCroix A.Z., Spangler L., Beasley J.M., et al. Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation. J. Clin. Endocrinol. Metab. 2011;96(9):E1380–E1387. doi: 10.1210/jc.2010-3027. - DOI - PMC - PubMed
-
- Daniels K., Abma J.C. Vol. 388. NCHS Data Brief; 2020. pp. 1–8. (Current contraceptive status among women aged 15–49: United States, 2017–2019). - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials